NCT05853536 is a clinical trial in Cardiovascular Diseases, sponsored by University of Leicester.

Who is sponsoring NCT05853536?

NCT05853536 is sponsored by University of Leicester.

What condition does NCT05853536 study?

NCT05853536 studies Cardiovascular Diseases.

Is NCT05853536 still recruiting?

NCT05853536 is currently status unknown. Last updated 10 May 2023.

Last reviewed 2023-05-10 · How we verify

NCT05853536

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

In Silico Trials of Surgical Interventions

Status unknown Last updated 10 May 2023

What this trial tests

trial in Cardiovascular Diseases in 13,977,257 participants. Status unknown.

Timeline

1 August 2019

Primary endpoint
1 August 2023

1 August 2024

Quick facts

Lead sponsor	University of Leicester
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	13,977,257
Start date	1 August 2019
Primary completion	1 August 2023
Estimated completion	1 August 2024
Sites	1 location across United Kingdom

Conditions studied

Cardiovascular Diseases — all drugs for Cardiovascular Diseases →

Sponsor

University of Leicester

Who can join

18 and older, any sex, with Cardiovascular Diseases. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The project aims to establish a database of cardiovascular patients using HES and linked mortality data. This database will be used to model trials in silico with the aim of informing the design of future cardiovascular trials in the United Kingdom.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Study design for an emulated trial of a 2 arm, parallel, stratified, adaptive, RCT of CABG versus PCI in people requiring myocardial revascularization at high risk (High-Risk REVASC).
Liao W, Rashid M, Brookes CL, Barber S, et al · · 2026 · PMID 41638385 · DOI 10.1016/j.ahj.2026.107368
Validation of “Days Alive and out of Hospital” as an Outcome Measure After Coronary Artery Bypass Graft Surgery, Acute Coronary Syndrome and Heart Failure Hospitalisation
Grant R, Liao W, Miksza J, Roman M, et al · · 2024 · DOI 10.1101/2024.02.12.24302587

Verify or expand the search:

Other recruiting trials for Cardiovascular Diseases

Currently open trials in the same condition.

NCT07442578 — Impact of Exercise Intensity on Cardiac Health in Young Adult Survivors of Childhood Cancer: The PULSE Trial · NA · active not recruiting
NCT07426263 — Effectiveness of a Therapeutic Education Program on Female Sexuality in Women Attending Cardiac Rehabilitation. · NA · active not recruiting
NCT06535568 — Single vs. Dual Antiplatelet Therapy in Elderly or HBR Patients Undergoing Percutaneous Intervention With DCB (PICCOLETO · NA · recruiting
NCT07324278 — Hybrid Stroke Rehab With Mirror Priming · NA · recruiting
NCT07286578 — A Prospective, Multicenter, Randomized Controlled Trial to Investigate the Value of Coronary CT Angiography in the Under · NA · recruiting

Other University of Leicester trials

Trials by the same sponsor.

NCT07389785 — Age Related Chromatin Remodelling as a Therapeutic Target for Organ Protection in Cardiac Surgery · active not recruiting
NCT07014579 — Using Heart Electrical Signals to Study How Well Treatments Prevent Dangerous Heart Rhythms in Active People · not yet recruiting
NCT06955663 — Exercise Support and Rehabilitation for Patients After Spontaneous Coronary Artery Dissection · NA · recruiting
NCT06629675 — Make Every Step Count: Personalised Music Feedback to Walking for People Living With COPD · NA · recruiting
NCT06844656 — Understanding the Increased Risk of Atrial Fibrillation in Athletes: a Case-control Study · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05853536 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Leicester
Last refreshed: 10 May 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05853536.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing